Morgan Stanley’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-240
| Closed | -$70 | – | 8152 |
|
|
2024
Q2 | $70 | Sell |
240
-1,375
| -85% | -$401 | ﹤0.01% | 7421 |
|
|
2024
Q1 | $23.2K | Buy |
1,615
+175
| +12% | +$2.52K | ﹤0.01% | 6442 |
|
|
2023
Q4 | $16.8K | Buy |
1,440
+643
| +81% | +$7.51K | ﹤0.01% | 6708 |
|
|
2023
Q3 | $12K | Buy |
797
+77
| +11% | +$1.16K | ﹤0.01% | 6664 |
|
|
2023
Q2 | $14.9K | Buy |
+720
| New | +$14.9K | ﹤0.01% | 6661 |
|
|
2023
Q1 | – | Sell |
-240
| Closed | -$2.57K | – | 7863 |
|
|
2022
Q4 | $2.57K | Hold |
240
| – | – | ﹤0.01% | 7306 |
|
|
2022
Q3 | $3K | Sell |
240
-50
| -17% | -$625 | ﹤0.01% | 7412 |
|
|
2022
Q2 | $10K | Buy |
290
+288
| +14,400% | +$9.93K | ﹤0.01% | 7216 |
|
|
2022
Q1 | $0 | Sell |
2
-1,145
| -100% | – | ﹤0.01% | 8188 |
|
|
2021
Q4 | $237K | Buy |
1,147
+1,143
| +28,575% | +$236K | ﹤0.01% | 5978 |
|
|
2021
Q3 | $1K | Sell |
4
-20
| -83% | -$5K | ﹤0.01% | 7822 |
|
|
2021
Q2 | $6K | Buy |
24
+4
| +20% | +$1K | ﹤0.01% | 7357 |
|
|
2021
Q1 | $5K | Buy |
+20
| New | +$5K | ﹤0.01% | 7122 |
|